Kuwait Petroleum subsidiary acquires 25% stake in China Wanhua Chemical Group
Kuwait Petrochemical Industries, a subsidiary of Kuwait's state-owned oil company, said on the 26th that it had signed an agreement to acquire a 25% stake in China Wanhua Chemical Group.
The company did not disclose the value of the transaction, but said it was Kuwait's largest investment in China's petrochemical industry.
Under the agreement, Kuwait Petrochemical Industries will acquire several industrial units of the group in Yantai, China, which specialize in the production of a variety of petrochemical products, including propylene oxide and acrylic acid.
The company said this will help diversify the Kuwaiti company's high-value product portfolio.
You May Interested In
2026-10-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Chemicals Take the Hit as China's Markets Thin Out — Wanhua, Juhua Chemical Slide Over 2%
-
Wanhua's BorsodChem Restarts 650,000 T/Y of MDI and TDI Capacity in Europe
-
Wanhua Shuts 1.1 Million-Tonne Yantai MDI Unit for 45-Day Maintenance
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
Sichuan’s 120,000 Tons Approved, Shandong’s 500,000 Tons on the Way:Is Wanhua Chemical Set to “Break Through” the LFP Market?
-
Global MDI/TDI Plants Enter Peak Maintenance Season, Wanhua Chemical’s Hungary Shutdown Draws Market Attention
-
The Petrochemical Industries Company and Wanhua Chemical Group Sign Agreement to Strengthen Cooperation
-
SUEZ Builds China's Largest Industrial Membrane Desalination Plant for Wanhua Chemical Penglai Industrial Park to Meet Industrial Needs and Protect Scarce Water Resources
-
Wanhua Chemical Expands HMDI and HDI Production Capacity to Lead the Global Market
-
Air Liquide to invest €60 million in ASU for Wanhua Chemical Group
Recommend Reading
-
![Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy]()
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
![Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera]()
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
![Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera]()
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
![Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook]()
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
![Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy]()
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
![Premium Global Chemical Sourcing Requests (25-28Jun, 2026)]()
Premium Global Chemical Sourcing Requests (25-28Jun, 2026)
-
![After Two Rounds of Price Cuts, the Coke Market Stabilizes in China]()
After Two Rounds of Price Cuts, the Coke Market Stabilizes in China
-
![Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic]()
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
![Supply remains generally loose, the acrylonitrile market fluctuates within a range]()
Supply remains generally loose, the acrylonitrile market fluctuates within a range
-
![Polyester Bottle Chip Spot Price Rises on the 14th]()
Polyester Bottle Chip Spot Price Rises on the 14th
